Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Exp Neurol. 2020 Apr 2;329:113289. doi: 10.1016/j.expneurol.2020.113289

Fig. 6.

Fig. 6.

TCA Cycle intermediates and ATP content in males. A. Acetyl CoA content in injured vs. optimal treatment groups. B. Citrate synthase activity in injured vs. optimal treatment groups. C. ATP content in injured vs. optimal treatment groups *compared to sham, #compared to CCI. p < .05.